0001140361-23-000825.txt : 20230106
0001140361-23-000825.hdr.sgml : 20230106
20230106165915
ACCESSION NUMBER: 0001140361-23-000825
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230105
FILED AS OF DATE: 20230106
DATE AS OF CHANGE: 20230106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CONN GREGORY
CENTRAL INDEX KEY: 0001770008
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 23515730
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDS Biotechnology Corp
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25B VREELAND ROAD
STREET 2: SUITE 300
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 25B VREELAND ROAD
STREET 2: SUITE 300
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
FORMER COMPANY:
FORMER CONFORMED NAME: Edge Therapeutics, Inc.
DATE OF NAME CHANGE: 20090911
4
1
form4.xml
X0306
4
2023-01-05
0001472091
PDS Biotechnology Corp
PDSB
0001770008
CONN GREGORY
C/O PDS BIOTECHNOLOGY CORPORATION
25B VREELAND ROAD, SUITE 300
FLORHAM PARK
NJ
07932
true
Chief Scientific Officer
Employee Stock Option (Right to Buy)
11.61
2023-01-05
4
A
0
137200
0
A
2033-01-05
Common Stock
137200
137200
D
This option, representing a right to purchase a total of 137,200 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027.
/s/ Gregory Conn
2023-01-06